Zacks Research Weighs in on Marsh & McLennan Companies, Inc.’s Q2 2024 Earnings (NYSE:MMC)

Marsh & McLennan Companies, Inc. (NYSE:MMC) – Research analysts at Zacks Research decreased their Q2 2024 earnings per share estimates for shares of Marsh & McLennan Companies in a research note issued on Thursday, May 2nd. Zacks Research analyst D. Chatterjee now forecasts that the financial services provider will earn $2.36 per share for the quarter, down from their previous estimate of $2.40. The consensus estimate for Marsh & McLennan Companies’ current full-year earnings is $8.71 per share. Zacks Research also issued estimates for Marsh & McLennan Companies’ Q3 2024 earnings at $1.63 EPS, FY2024 earnings at $8.70 EPS, Q1 2025 earnings at $2.77 EPS, Q2 2025 earnings at $2.45 EPS, Q3 2025 earnings at $1.93 EPS, Q4 2025 earnings at $2.16 EPS, FY2025 earnings at $9.32 EPS, Q1 2026 earnings at $3.06 EPS and FY2026 earnings at $10.09 EPS.

A number of other equities research analysts have also recently weighed in on MMC. JPMorgan Chase & Co. increased their price target on Marsh & McLennan Companies from $190.00 to $198.00 and gave the company a “neutral” rating in a research note on Monday, April 8th. UBS Group increased their price target on Marsh & McLennan Companies from $236.00 to $238.00 and gave the company a “buy” rating in a research note on Monday, April 22nd. TD Cowen increased their price objective on Marsh & McLennan Companies from $189.00 to $201.00 and gave the stock a “hold” rating in a research report on Monday, April 22nd. Royal Bank of Canada increased their price objective on Marsh & McLennan Companies from $208.00 to $210.00 and gave the stock a “sector perform” rating in a research report on Friday, April 19th. Finally, Wells Fargo & Company increased their price objective on Marsh & McLennan Companies from $212.00 to $213.00 and gave the stock an “equal weight” rating in a research report on Friday, April 19th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus target price of $207.69.

Marsh & McLennan Companies Stock Up 1.1 %

MMC opened at $203.74 on Monday. Marsh & McLennan Companies has a 1-year low of $171.47 and a 1-year high of $209.20. The stock’s fifty day simple moving average is $202.81 and its 200 day simple moving average is $197.67. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.97. The stock has a market cap of $100.39 billion, a PE ratio of 25.86, a price-to-earnings-growth ratio of 3.31 and a beta of 0.90.

Marsh & McLennan Companies (NYSE:MMC) last released its quarterly earnings data on Thursday, April 18th. The financial services provider reported $2.89 EPS for the quarter, beating the consensus estimate of $2.80 by $0.09. Marsh & McLennan Companies had a return on equity of 34.14% and a net margin of 16.84%. The company had revenue of $6.50 billion during the quarter, compared to the consensus estimate of $6.38 billion. During the same quarter in the prior year, the firm posted $2.53 EPS. The firm’s revenue for the quarter was up 9.7% compared to the same quarter last year.

Hedge Funds Weigh In On Marsh & McLennan Companies

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of Marsh & McLennan Companies by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 43,798,034 shares of the financial services provider’s stock worth $8,298,414,000 after acquiring an additional 180,128 shares during the period. FMR LLC increased its holdings in Marsh & McLennan Companies by 0.3% in the third quarter. FMR LLC now owns 19,423,136 shares of the financial services provider’s stock worth $3,696,223,000 after purchasing an additional 61,408 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Marsh & McLennan Companies by 32.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,243,245 shares of the financial services provider’s stock worth $1,940,789,000 after purchasing an additional 2,526,701 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in Marsh & McLennan Companies by 0.4% in the third quarter. Ameriprise Financial Inc. now owns 8,278,659 shares of the financial services provider’s stock worth $1,575,881,000 after purchasing an additional 31,821 shares in the last quarter. Finally, Morgan Stanley increased its holdings in Marsh & McLennan Companies by 2.5% in the third quarter. Morgan Stanley now owns 6,145,046 shares of the financial services provider’s stock worth $1,169,403,000 after purchasing an additional 150,655 shares in the last quarter. 87.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Dean Michael Klisura sold 9,994 shares of Marsh & McLennan Companies stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $205.00, for a total transaction of $2,048,770.00. Following the sale, the chief executive officer now directly owns 20,935 shares of the company’s stock, valued at $4,291,675. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, VP Stacy Mills sold 1,461 shares of Marsh & McLennan Companies stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $209.16, for a total value of $305,582.76. Following the transaction, the vice president now directly owns 2,923 shares of the company’s stock, valued at $611,374.68. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Dean Michael Klisura sold 9,994 shares of Marsh & McLennan Companies stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $205.00, for a total value of $2,048,770.00. Following the completion of the transaction, the chief executive officer now directly owns 20,935 shares in the company, valued at $4,291,675. The disclosure for this sale can be found here. Over the last three months, insiders have sold 36,751 shares of company stock valued at $7,448,163. 0.35% of the stock is currently owned by corporate insiders.

Marsh & McLennan Companies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Thursday, April 4th will be paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, April 3rd. Marsh & McLennan Companies’s payout ratio is 36.04%.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.